Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in! Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Emerging Approaches in Schizophrenia
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • View All
Back to top Open menu arrow

Save Save

Share Share

Cite Cite

Reprints
Sections
No sections available
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Access icon
Bipolar Disorder

Insights June 1, 2021

Complex Polypharmacy in Bipolar Disorder

Joseph F. Goldberg, MD

Which bipolar disorder patients are more likely to receive more than 2 medications, and why? In this video, Dr Goldberg discusses the findings of his recent systematic review focusing on polypharmacy in bipolar disorder.

Read the full article

Save Save

Share Share

Cite Cite

Related News Articles

How Patients Talk May Matter More Than What They Say AI Predicts Schizophrenia Using Patient Records Ketogenic Diet Shows Promise for Bipolar Disorder

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder Pharmacokinetics of Olanzapine Intranasal Spray vs Olanzapine IM Suicide and Benzodiazepine Use in Veterans With Bipolar Disorder

Related PCC Articles

Readability of Bipolar Disorder Measures Oxcarbazepine/Aripiprazole Interaction and Bipolar Relapse A Tale of 2 Lithium Toxicities

Vol 86 • 2025 • Number 2

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue

Related Articles

JCP
Preventing Functional Deterioration in Patients With Bipolar Disorder
Insights

Preventing Functional Deterioration in Patients With Bipolar Disorder

April 15, 2021

Dr Joseph Goldberg and others explain why intervening early with effective treatment is critically important for preventing episodes and preserving functioning in patients with bipolar disorder.
Mauricio Tohen , Joseph F. Goldberg , Youssef Hassoun , et al
JCP
Polypharmacy and the Concept of a “Foundational Treatment” for Bipolar Disorder
Insights

Polypharmacy and the Concept of a “Foundational Treatment” for Bipolar Disorder

April 15, 2021

Learn how simplifying a bipolar disorder treatment regimen, with a single agent acting as the “foundation” and others added when needed, may both improve patient morale and be effective...
Mauricio Tohen , Joseph F. Goldberg , Youssef Hassoun , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap